Liminatus Pharma, Inc. LIMN
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-05-18
Liminatus Pharma, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| CITADEL ADVISORS LLC | 677,518 | $116,465 |
| D. E. Shaw & Co., Inc. | 83,353 | $3,334 |
| MILLENNIUM MANAGEMENT LLC | 70,616 | $2,825 |
Source: SEC EDGAR filings · CIK 0001971387 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.